Next »
Clinical Microbiology Newsletter
Volume 32, Issue 6
, Pages 41-49
, 15 March 2010
Code Sepsis: Rapid Methods To Diagnose Sepsis and Detect Hematopathogens: Part II: Challenges to the Laboratory Diagnosis of Sepsis
References
-
.
Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria
.
Int. J. Antimicrob. Agents
. 2007;30(Suppl. 1):S7–S15
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock . Crit. Care Med. . 2006;34:1589–1596
-
.
Rapid identification of methicillin-resistant staphylococci bacteremia among intensive care unit patients
.
Medscape J. Med.
. 2008;10:126
- Performance of two tube coagulase methods for rapid identification of Staphylococcus aureus from blood cultures and their impact on antimicrobial management . Clin. Microbiol. Infect. . 2008;14:510–513
- . Rapid differentiation of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus from blood cultures by use of a direct cefoxitin disk diffusion test . J Clin. Microbiol. . 2008;46:3836–3838
- . Rapid identification of Staphylococcus aureus in blood cultures by use of the direct tube coagulase test . J. Clin. Microbiol. . 2007;45:2267–2269
- Practical therapeutic application of the Oxoid PBP2′ latex agglutination test for the rapid identification of methicillin-resistant Staphylococcus aureus in blood cultures . Am. J. Clin. Pathol. . 2002;118:287–291
- . Rapid immunodiagnosis of streptococci and enterococci in blood cultures . APMIS . 2001;109:284–288
- Rapid differentiation of Candida albicans from non-albicans species by germ tube test directly from BacTAlert blood culture bottles . Mycoses . 2007;50:48–51
- . Use of BioRad plating agar MRSASelect for the daily detection of methicillin resistant staphylococci isolated from samples taken from blood culture bottles . Pathol. Biol. (Paris) . 2006;54:506–509
- . Utility of the pneumoslide test in identification of Streptococcus pneumoniae in blood cultures and its relation to capsular serotype . J. Clin. Microbiol. . 2009;47:1559–1561
- Identification and susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by direct inoculation from positive BACTEC blood culture bottles into Vitek 2 . J Clin. Microbiol. . 2004;42:7–11
-
Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures
.
J. Microbiol. Immunol. Infect.
. 2008;41:259–264
- Evaluation of MicroScan and Phoenix system for rapid identification and susceptibility testing using direct inoculation from positive BACTEC blood culture bottles . Korean J. Lab. Med. . 2009;29:25–34
- . Use of the BD PHOENIX Automated Microbiology System for direct identification and susceptibility testing of gram-negative rods from positive blood cultures in a three-phase trial . J. Clin. Microbiol. . 2004;42:1466–1470
- . Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures . J. Clin. Microbiol. . 2003;41:4705–4707
- Evaluation of the Merlin MICRONAUT system for rapid direct susceptibility testing of gram-positive cocci and gram-negative bacilli from positive blood cultures . J. Clin. Microbiol. . 2007;45:789–795
-
Direct antifungal susceptibility testing of positive Candida blood cultures by Sensititre YeastOne
.
New Microbiol.
. 2009;32:179–184
-
Molecular biological detection of pathogens in patients with sepsis
.
Potentials, limitations and perspectives. Anaesthesist
. 2008;57:326–337
- . Emergency medicine and the surviving sepsis campaign: an international approach to managing severe sepsis and septic shock . Ann. Emerg. Med. . 2005;46:228–231
- Early goal-directed therapy in the treatment of severe sepsis and septic shock . N. Engl. J. Med. . 2001;345:1368–1377
-
Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity
.
Can. Med. Assoc. J.
. 2005;173:1054–1065
- Simultaneous detection of herpes simplex virus types 1 and 2 by real-time PCR and pyrosequencing . J. Clin. Virol. . 2005;33:25–34
- Rapid diagnosis of Staphylococcus aureus bacteremia using S. aureus PNA FISH . Eur. J. Clin. Microbiol. Infect. Dis. . 2004;23:396–398
- Direct identification of Staphylococcus aureus from positive blood culture bottles . J. Clin. Microbiol. . 2003;41:889–891
- Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes . J. Clin. Microbiol. . 2001;39:4138–4141
- Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes . J. Clin. Microbiol. . 2002;40:247–251
- Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles . J. Clin. Microbiol. . 2002;40:2182–2186
- . Direct identification of major blood culture pathogens, including Pseudomonas aeruginosa and Escherichia coli, by a panel of fluorescence in situ hybridization assays using peptide nucleic acid probes . J. Clin. Microbiol. . 2005;43:1947–1949
-
.
PNA FISH: an intelligent stain for rapid diagnosis of infectious diseases
.
Exp. Rev. Mol. Diagn.
. 2003;3:649–655
- Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures . J. Clin. Microbiol. . 2005;43:2909–2912
- Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures . Diagn. Microbiol. Infect. Dis. . 2006;54:277–282
- Rapid identification of Staphylococcus aureus in blood cultures by a combination of fluorescence in situ hybridization using peptide nucleic acid probes and flow cytometry . J. Clin. Microbiol. . 2005;43:4855–4857
- . Direct susceptibility testing of positive blood cultures by using Sensititre broth microdilution plates . J. Clin. Microbiol. . 2003;41:4751–4754
-
Oliveria, K.M. et al. 2007. Rapid identification of S. aureus and differentiation between MRSA and MSSA from blood culture bottles using S. aureus PNA FISH and MRSA EVIGENE. Presented at the IDSA 2005 Annual Meeting.
- Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles . J. Clin. Microbiol. . 2008;46:50–55
- Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species . J. Clin. Microbiol. . 2007;45:3802–3803
-
Toombs, L. et al. 2006. Impact of peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH) for enterococcocal blood stream infections. Presented at the IDSA 2006 Annual Meeting.
- Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy . Antimicrob. Agents Chemother. . 2008;52:3558–3563
- Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures . J. Antimicrob. Chemother. . 2006;58:154–158
-
Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time
.
Ther. Clin. Risk Manag.
. 2008;4:637–640
- Guidelines for treatment of candidiasis . Clin. Infect. Dis. . 2004;38:161–189
- Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs . J. Clin. Microbiol. . 2006;44:3381–3383
- Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays . J. Clin. Microbiol. . 2009;47:823–826
- Community-associated methicillin-resistant Staphylococcus aureus: current status and molecular epidemiological perspective . Kansenshogaku Zasshi . 2004;78:459–469
- . PBP 2a mutations producing very high-level resistance to beta-lactams . Antimicrob. Agents Chemother. . 2004;48:453–459
- Partial excision of the chromosomal cassette containing the methicillin resistance determinant results in methicillin-susceptible Staphy lococcus aureus . J. Clin. Microbiol. . 2005;43:4191–4193
- Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus . J. Clin. Microbiol. . 2007;45:2011–2013
- Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures . J. Clin. Microbiol. . 2007;45:2191–2196
- Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottles . J. Clin. Microbiol. . 2009;47:1689–1694
- . Procalcitonin in patients with and without immunosuppression and sepsis . Infection . 1996;24:434–436
-
Procalcitonin for early diagnosis of bacteraemia in children with cancer
.
Ugeskr. Laeger
. 2007;169:138–142
- Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? . Intensive Care Med. . 2002;28:1351–1356
-
.
Procalcitonin as a marker of the systemic inflammatory response to infection
.
Medicina
. 2004;40:696–701
- Procalcitonin in comparison to C-reactive protein as markers of the course of sepsis in severely immunocompromised children after bone marrow transplantation . Klin. Padiatr. . 2000;212:10–15
- . Procalcitonin for the clinical laboratory: a review . Pathology . 2007;39:383–390
- Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker . Pediatr. Infect. Dis. J. . 2003;22:895–903
- . Procalcitonin as an early marker of infection in neonates and children . Lancet Infect. Dis. . 2004;4:620–630
- Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit . Crit. Care Med. . 2000;28:977–983
- Procalcitonin predicts patients at low riskof death from community-acquired pneumonia across all CRB-65 classes . Eur. Respir. J. . 2008;31:349–355
- Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children . Cardiol. Young. . 2003;13:161–167
-
.
Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients
.
Crit. Care
. 2006;10:R1
-
Brahms Aktiengesellschaft. 2006. Instruction manual BRAHMS PCT sensitive KRYPTOR product insert.
-
.
Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria
.
Int. J. Antimicrob. Agents
. 2007;30(Suppl. 1):S7–S15
- PCR evaluation of false-positive signals from two automated blood-culture systems . J. Med. Microbiol. . 2006;55:53–57
-
.
Pathogen detection in the genomic era
.
In:
Tang Y
editors.
Advanced techniques in diagnostic microbiology
. New York: Springer Verlag; 2006;p. 505–523
-
.
Future trends in diagnosis of infections in the immunocompromised population
.
In:
Hayden RT
, et al.
editor.
Diagnostic microbiology of the immunocompromised Host
. Washington, DC: ASM Press; 2008;
- Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis . Eur. J. Clin. Microbiol. Infect. Dis. . 2009;28:569–573
- Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis . BMC Infect. Dis. . 2009;9:126
- Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies . J. Med. Microbiol. . 2008;57:601–604
- . Use of pyrosequencing of 16S rRNA fragments to differentiate between bacteria responsible for neonatal sepsis . J. Mol. Diagn. . 2005;7:105–110
- StaphPlex system for rapid and simultaneous identification of antibiotic resistance determinants and Panton-Valentine leukocidin detection of staphylococci from positive blood cultures . J. Clin. Microbiol. . 2007;45:1867–1873
- Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates . Diagn. Microbiol. Infect. Dis. . 2009;63:403–408
- Molecular genotyping of microbes by multilocus PCR and mass spectrometry: a new tool for hospital infection control and public health surveillance . Methods Mol. Biol. . 2009;551:71–87
- Ibis T5000: a universal biosensor approach for microbiology . Nat. Rev. Microbiol. . 2008;6:553–558
- Rapid determination of quinolone resistance in Acinetobacter spp . J. Clin. Microbiol. . 2009;47:1436–1442
- Rapid molecular genotyping and clonal complex assignment of Staphylococcus aureus isolates by PCR coupled to electrospray ionization-mass spectrometry . J. Clin. Microbiol. . 2009;47:1733–1741
-
Rapid molecular characterization of S. aureus isolates by PCR/ESI-MS and correlation with phenotype (accpeted for publication)
.
J. Clin. Microbiol.
. 2009;
- Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need . J. Clin. Microbiol. . 2004;42:2879–2883
- . Molecular detection of antimicrobial resistance . Clin. Microbiol. Rev. . 2001;14:836–871
-
.
Detection and characterization of antimicrobial resistance genes in bacteria
.
In:
Murray PR
, et al.
editor.
Manual of clinical microbiology
. Washington, DC: ASM Press; 2003;p. 1196–1213
-
.
Detection of antimicrobial resistance genes and mutations associated with antimicrobial resistance in microorganisms
.
In:
Persing DH
, et al.
editor.
Molecular microbiology: diagnostic principles and practice
. Washington, DC: ASM Press; 2004;p. 391–406
-
.
Molecular detection of antifungal resistance
.
In:
Persing DH
, et al.
editor.
Molecular microbiology: diagnostic principles and practice
. Washington, DC: ASM Press; 2004;p. 569–575
Editor's Note: Part I of this article appeared in the March 1, 2010 issue of CMN, Volume 32, Number 5.
PII: S0196-4399(10)00010-3
doi: 10.1016/j.clinmicnews.2010.03.001
© 2010 Elsevier Inc. All rights reserved.
Next »
Clinical Microbiology Newsletter
Volume 32, Issue 6
, Pages 41-49
, 15 March 2010
